Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: A protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy

CASTLE Group King's College London, LUCY BRAY, BERNIE CARTER, Amber Collingwood, Georgia Cook, Luci Wiggs, Deb Pal, Paul Gringras, HOLLY SARON, Ali Rouncefield-Swales, Christopher Morris

Research output: Contribution to journalArticle (journal)peer-review

5 Downloads (Pure)

Abstract

Introduction
Sleep and epilepsy have an established bi-directional relationship yet only one
randomised controlled clinical trial has assessed the effectiveness of behavioural sleep interventions for children with epilepsy. The intervention was successful, but was delivered via face-to-face educational sessions with parents, which are costly and non-scalable to population level. The Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E trial addresses this problem by comparing clinical- and cost-effectiveness in children with Rolandic epilepsy between standard care and standard care augmented with a novel, tailored parent-led CASTLE Online Sleep Intervention (COSI) that incorporates
evidence-based behavioural components.
Methods and analyses CASTLE Sleep-E is a UK-based, multi-centre, open label, active concurrent control, randomised, parallel-group, pragmatic superiority trial. A total of 110 children with Rolandic epilepsy will be recruited in out-patient clinics and allocated 1:1 to standard care (SC) or standard care augmented with COSI (SC + COSI). Primary clinical outcome is parent-reported sleep problem score (Children’s Sleep Habits Questionnaire). Primary health economic outcome is the Incremental Cost Effectiveness Ratio (National Health Service and Personal Social Services perspective, Child Health Utility 9D instrument). Parents and children (≥ 7 years) can opt into qualitative interviews and activities to share
their experiences and perceptions of trial participation and managing sleep with Rolandic epilepsy.
Ethics and dissemination The CASTLE Sleep-E protocol was approved by the Health Research Authority East Midlands (HRA) – Nottingham 1 Research Ethics Committee, reference: 21/EM/0205. Trial results will be disseminated to scientific audiences, families, professional groups, managers, commissioners, and policy makers. Pseudo-anonymised Individual Patient Data will be made available after dissemination on reasonable request.
Registration details ISRCTN registry (Trial ID: ISRCTN13202325, prospective registration 09/Sep/2021). See Supplemental Table 1 for the World Health Organisation Trial Registration Data Set (Version 1.3.1).
Original languageEnglish
JournalBMJ Open
Publication statusAccepted/In press - 22 Dec 2022

Keywords

  • Epilepsy
  • Neurology
  • Paediatric neurology
  • Sleep Medicine
  • Clinical trials
  • Therapeutics
  • Qualitative research

Fingerprint

Dive into the research topics of 'Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: A protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy'. Together they form a unique fingerprint.

Cite this